Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2165
Gene Symbol: F13B
F13B 		0.300 Biomarker phenotype CTD_human A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosis. 16241947 2005
Entrez Id: 5328
Gene Symbol: PLAU
PLAU 		0.300 Therapeutic phenotype CTD_human Thrombolytic therapy in heparin-associated thrombocytopenia with thrombosis. 3488869 1986
Entrez Id: 5327
Gene Symbol: PLAT
PLAT 		0.300 Therapeutic phenotype CTD_human Heparin induced thrombocytopenia and re-thrombosis associated with warfarin and fondaparinux in a child. 19415734 2009
Entrez Id: 4018
Gene Symbol: LPA
LPA 		0.300 Biomarker phenotype CTD_human Lipoprotein (a): its role in childhood thromboembolism. 9164807 1997
Entrez Id: 5328
Gene Symbol: PLAU
PLAU 		0.300 Therapeutic phenotype CTD_human Clinical and economic outcomes in thrombolytic treatment of peripheral arterial occlusive disease and deep venous thrombosis. 15557913 2004
Entrez Id: 2152
Gene Symbol: F3
F3 		0.300 Biomarker phenotype CTD_human Administration of a small molecule tissue factor/factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding time. 14967414 2003
Entrez Id: 5328
Gene Symbol: PLAU
PLAU 		0.300 Therapeutic phenotype CTD_human Fibrinogenolysis and fibrinolysis in normal volunteers and patients with thrombosis after infusion of urokinase. 3161212 1985
Entrez Id: 2056
Gene Symbol: EPO
EPO 		0.300 Biomarker phenotype CTD_human Deep vein thrombosis occurring on treatment of patients receiving thalidomide with erythropoietin. 17547733 2007
Entrez Id: 1437
Gene Symbol: CSF2
CSF2 		0.300 Biomarker phenotype CTD_human Venous thrombosis occurred in 17% of patients (concurrent v sequential GM-CSF, 29% v 5%; P2 = .08). 8120554 1994
Entrez Id: 5340
Gene Symbol: PLG
PLG 		0.300 Therapeutic phenotype CTD_human Thirteen patients with up to two-week-old phlebothromboses were treated with streptokinase and human plasminogen according to a fixed dosage scheme. 7215189 1981
Entrez Id: 5328
Gene Symbol: PLAU
PLAU 		0.300 Therapeutic phenotype CTD_human Controlled multicenter pilot study of urokinase- heparin and streptokinase in deep vein thrombosis. 6359570 1983
Entrez Id: 2147
Gene Symbol: F2
F2 		0.570 Biomarker phenotype LHGDN Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis. 15528884 2005
Entrez Id: 2147
Gene Symbol: F2
F2 		0.570 GeneticVariation phenotype LHGDN However, non-OO blood group contributed significantly to the expression of venous thrombosis associated with both factor V Leiden (OR: 1.76; 95%CI: 1.06-2.91) and prothrombin 20210A (OR: 2.17; 95%CI: 1.33-3.53). 18387978 2008
Entrez Id: 2147
Gene Symbol: F2
F2 		0.570 GeneticVariation phenotype LHGDN Factor V G1691A (FV-Leiden) and prothrombin (PRT) G20210A single nucleotide polymorphisms (SNPs) were associated with venous thrombosis among Caucasians. 16823828 2006
Entrez Id: 2147
Gene Symbol: F2
F2 		0.570 AlteredExpression phenotype LHGDN Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis. 17890946 2007
Entrez Id: 2147
Gene Symbol: F2
F2 		0.570 GeneticVariation phenotype LHGDN Association of prothrombin gene mutation with sepsis in a preterm with multiple intracardiac thrombi. 15839991 2005
Entrez Id: 2147
Gene Symbol: F2
F2 		0.570 GeneticVariation phenotype LHGDN To date, conflicting results have been reported for recurrent venous thrombosis in the patients with factor V Leiden and prothrombin G20210A mutation, since some studies have shown a higher risk for recurrent venous thrombosis in carriers of these two mutations than in non-carriers, and the last study showed higher risk only for carriers of double defect (homozygous or double heterozygous for this mutations). 17245631 2007
Entrez Id: 2147
Gene Symbol: F2
F2 		0.570 GeneticVariation phenotype LHGDN Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients. 18160601 2008
Entrez Id: 2153
Gene Symbol: F5
F5 		0.500 Biomarker phenotype LHGDN Factor V Leiden is associated with more distal location of deep vein thrombosis of the leg. 18182032 2008
Entrez Id: 2153
Gene Symbol: F5
F5 		0.500 GeneticVariation phenotype LHGDN However, non-OO blood group contributed significantly to the expression of venous thrombosis associated with both factor V Leiden (OR: 1.76; 95%CI: 1.06-2.91) and prothrombin 20210A (OR: 2.17; 95%CI: 1.33-3.53). 18387978 2008
Entrez Id: 2153
Gene Symbol: F5
F5 		0.500 GeneticVariation phenotype LHGDN Distinct association of factor V-Leiden and prothrombin G20210A mutations with deep venous thrombosis in Tunisia and Lebanon. 16823828 2006
Entrez Id: 2153
Gene Symbol: F5
F5 		0.500 Biomarker phenotype LHGDN No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study. 17353498 2007
Entrez Id: 2153
Gene Symbol: F5
F5 		0.500 GeneticVariation phenotype LHGDN Influence of factor V HR2 on thrombin generation and clinical manifestation in rare bleeding disorders. 16772740 2005
Entrez Id: 2153
Gene Symbol: F5
F5 		0.500 GeneticVariation phenotype LHGDN Factor V Leiden: is it the chief contributor to activated protein C resistance in Asian-Indian patients with deep vein thrombosis? 18342013 2008
Entrez Id: 2153
Gene Symbol: F5
F5 		0.500 GeneticVariation phenotype LHGDN HR2 haplotype in Arab population and patients with venous thrombosis in Kuwait. 15978104 2005